Michael Coyle

Title: Michael Coyle: Innovator in RNA-Guided Nucleases

Introduction

Michael Coyle is a prominent inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of biotechnology, particularly in the development of RNA-guided nucleases. With a total of 11 patents, Coyle's work has advanced the understanding and application of genetic engineering techniques.

Latest Patents

Coyle's latest patents focus on RNA-guided nucleases and their active fragments and variants. These patents describe compositions and methods for binding to a target sequence of interest. The compositions are designed for cleaving or modifying a target sequence, visualizing a target sequence, and modifying the expression of a sequence. They include RNA-guided nuclease (RGN) polypeptides, CRISPR RNAs, trans-activating CRISPR RNAs, guide RNAs, and nucleic acid molecules encoding these components. Additionally, the patents provide RGN systems that comprise an RNA-guided nuclease polypeptide and one or more guide RNAs.

Career Highlights

Michael Coyle is currently associated with Lifeedit Therapeutics, Inc., where he continues to innovate in the field of genetic engineering. His work has been instrumental in developing technologies that have the potential to revolutionize gene editing and therapeutic applications.

Collaborations

Coyle collaborates with notable colleagues, including Alexandra Briner Crawley and Tedd D Elich. These partnerships enhance the research and development efforts at Lifeedit Therapeutics, Inc.

Conclusion

Michael Coyle's contributions to the field of RNA-guided nucleases exemplify the innovative spirit of modern biotechnology. His patents and ongoing work continue to push the boundaries of genetic engineering, paving the way for future advancements in the field.